Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens
- PMID: 20224728
- PMCID: PMC2836507
Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens
Abstract
Size of breast cancer is essential in staging cancer to determine type and extent of patient management. This study was conducted to assess accuracy in estimating tumor size by MRI and gross using microscopy as gold standard. A retrospective study was done on 33 patients, 30-75 years, who underwent MRI of breasts with subsequent lumpectomy, 2002-2006, for invasive breast cancer. Size of lesion(s) on MRI and gross were compared with histological size. Of 37 lesions, 27 (73%) were invasive ductal (IDC) and 10 (27%) invasive lobular carcinoma (ILC). Tumor size by MRI matched histological size in 3%, underestimated 27%, and overestimated 70% of cases. Tumor size by gross matched histological size in 22%, underestimated 57%, and overestimated 22% of cases. MRI as an imaging modality and gross pathology both have significant limitations in measuring tumor size particularly in cases of invasive breast carcinoma. Random sectioning of lumpectomy specimen in invasive breast carcinoma may result in inaccurate staging of tumor by leading to false impression of tumor size and multi-focality and/or multi-centricity of tumor particularly in cases of ILC. Microscopic measurements of tumor size are necessary for accurate T-staging and recommended for appropriate patient management.
Keywords: Breast cancer; MRI; gross pathology; microscopic pathology; tumor size.
Figures
Comment in
-
Re: "Behjatnia B et al. "Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens". IntJ Clin Exp Pathol 2010;3(3):303-309".Int J Clin Exp Pathol. 2010 Apr 30;3(4):458-60. Int J Clin Exp Pathol. 2010. PMID: 20490337 Free PMC article. No abstract available.
References
-
- Greene FL, Page DL, Fleming ID, Firtz AG, Balch CM, Haller DG, Marrow M, et al., editors. 6th ed. New York: Springer; 2002. American Joint Committee on Cancer (AJCC) Cancer Staging Manual; pp. 221–40.
-
- Sobin LH, Wittekind CH. 6th edn. New York: Wiley; 2002. TNM Classification of Malignant Tumors.
-
- Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:966–78. - PubMed
-
- Pritt B, Ashikaga T, Oppenheimer RG, Weaver DL. Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod Pathol. 2004;17(8):905–10. - PubMed
-
- Apple SK, Suthar F. How do we measure a residual tumor size in istopathology (gold standard) after neoadjuvant chemotherapy? Breast. 2005;15(3):370–6. - PubMed